| 1. | | No longer recruiting | Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma |
| 2. | | Recruiting | Bortezomib and Fludarabine in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma |
| 3. | | No longer recruiting | Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Conditions: stage III multiple myeloma; refractory plasma cell neoplasm |
| 4. | | Recruiting | Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation
Condition: adult non-Hodgkin's lymphoma |
| 5. | | No longer recruiting | Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIA breast cancer; stage II breast cancer |
| 6. | | Completed | Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer |
| 7. | | No longer recruiting | Chemotherapy, Filgrastim, and Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Conditions: AIDS-related primary CNS lymphoma; primary central nervous system lymphoma |
| 8. | | Recruiting | Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
Conditions: stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer |
| 9. | | Recruiting | Combination Chemotherapy and Thalidomide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 10. | | No longer recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Gastrointestinal Cancer; hematopoietic and lymphoid cancer |
| 11. | | Suspended | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 12. | | Recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 13. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 14. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 15. | | No longer recruiting | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease
Conditions: HIV-associated Hodgkin's disease; AIDS-Related Lymphoma |
| 16. | | Recruiting | Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
Conditions: AIDS-related diffuse large cell lymphoma; AIDS-related diffuse mixed cell lymphoma; AIDS-related diffuse small cleaved cell lymphoma; ... |
| 17. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Conditions: recurrent adult lymphoblastic lymphoma; recurrent grade III follicular large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; ... |
| 18. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer |
| 19. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: extensive stage small cell lung cancer; Recurrent Small Cell Lung Cancer |
| 20. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Metastatic Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 21. | | Completed | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 22. | | Completed | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
Conditions: adult acute myelomonocytic leukemia (M4); adult acute differentiated monocytic leukemia (M5b); recurrent adult acute lymphocytic leukemia; ... |
| 23. | | Recruiting | Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
| 24. | | No longer recruiting | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; ... |
| 25. | | No longer recruiting | Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Donor Lymphocyte Infusion in Treating Women With Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
| 26. | | Recruiting | Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer
Conditions: anaplastic thyroid cancer; recurrent thyroid cancer |
| 27. | | No longer recruiting | Combretastatin A4 Phosphate in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 28. | | No longer recruiting | Compassionate Use Program of Campath-1H in Patients With Refractory Prolymphocytic Leukemia or Chronic Lymphocytic Leukemia
Conditions: refractory chronic lymphocytic leukemia; Prolymphocytic Leukemia |
| 29. | | Recruiting | Cyclophosphamide With or Without Rituximab and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Condition: adult non-Hodgkin's lymphoma |
| 30. | | Recruiting | Docetaxel With or Without Bevacizumab Followed by Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Locally Advanced Breast Cancer
Conditions: stage IV breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; Male Breast Cancer |
| 31. | | No longer recruiting | Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer
Conditions: stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
| 32. | | Recruiting | Donor Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
| 33. | | Suspended | Erlotinib Plus Docetaxel in Treating Patients With Stage IV or Recurrent Breast Cancer
Conditions: recurrent breast cancer; stage IV breast cancer; Male Breast Cancer |
| 34. | | Recruiting | Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer |
| 35. | | No longer recruiting | Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed or Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome
Condition: Leukemia |
| 36. | | Recruiting | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer |
| 37. | | Recruiting | Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
| 38. | | No longer recruiting | Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
Conditions: stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas |
| 39. | | Completed | Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia After Stem Cell Transplantation
Conditions: recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia |
| 40. | | Recruiting | Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Conditions: adult brain tumor; adult non-Hodgkin's lymphoma; adult solid tumor |
| 41. | | Recruiting | GW786034 in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 42. | | Completed | HER-2 Protein Vaccine in Treating Women With Breast Cancer
Conditions: stage IV breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer |
| 43. | | Recruiting | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 44. | | Completed | Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure
Conditions: adult solid tumor; central nervous system cancer; Gastrointestinal Cancer; hematopoietic and lymphoid cancer |
| 45. | | Recruiting | Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
Condition: anaplastic thyroid cancer |
| 46. | | Recruiting | Induction Therapy Using Cisplatin, Etoposide, and Radiation Therapy Followed By Consolidation Therapy Using Gemcitabine With or Without Docetaxel in Treating Patients With Unresectable Stage IIIB Non-Small Cell Lung Cancer
Condition: Non-small cell lung cancer |
| 47. | | No longer recruiting | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; renal clear cell carcinoma; recurrent renal cell cancer |
| 48. | | Completed | Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 49. | | No longer recruiting | Letrozole With or Without CCI-779 in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Conditions: stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer |
| 50. | | No longer recruiting | Letrozole With or Without Tipifarnib in Treating Women With Locally Advanced, Locally Recurrent, or Metastatic Breast Cancer
Condition: Breast Cancer |
